Will Trump's Drug Price Cuts Happen? Expert Casts Doubt

Pharmaceutical Industry's Grip on Drug Prices: Skepticism Grows Over Trump's 59% Cut Promise. Washington D.C. - Donald Trump's recent promise to slash drug prices by 59% has been met with skepticism, particularly from healthcare analyst Justin Moore, known online as TheD3List. Moore, in a recent TikTok video, argues that the pharmaceutical industry's considerable power makes such a dramatic price reduction highly improbable. He points to past attempts to regulate drug prices, noting their consistent failure. "They always come out on top," Moore states in his video, "They never lose." This assertion is backed by his citing of past legislative attempts to control drug costs, where the industry successfully thwarted efforts. Moore's analysis highlights the industry's significant financial resources and political influence, suggesting their ability to resist price controls. The video concludes with a call to examine the industry's influence across various sectors. While the sentiment expressed is critical, the presentation of historical examples adds a layer of factual grounding to the argument. The video's popularity, as evidenced by its views and shares, indicates considerable public interest in this critical issue.